HyperRAB

Generic name: rabies immune globulin (human)

Used for: Preventing rabies after a possible exposure

How do you pay?

How to pay the least

Ask for the cash price

HyperRAB

HyperRAB is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for HyperRAB’s cash price, and one or two other pharmacies too.

Free from the maker, if you qualify Hypermunes Patient Assistance Program. Earn an annual gross income of 250% of the Federal Poverty Level (FPL) or less.

See if you qualify 

Compare every option

Question
Brand nameHyperRAB
Authorized genericrabies immune globulin (human)
Regular genericrabies immune globulin (human)
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as HyperRAB?
The original
–
–

Brand nameNo maker’s card

We didn’t find a savings card or cash price from HyperRAB’s maker. Ask the pharmacy for HyperRAB’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is HyperRAB itself, from the same company, sold without the brand name, and usually for less. For now HyperRAB is the only choice; ask the pharmacy for its cash price, or your plan what it charges.

Regular genericNot sold

HyperRAB is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for HyperRAB’s cash price, or your plan what it charges.

What it’s used for

What the FDA label says

HYPERRAB® is a human rabies immune globulin indicated for postexposure prophylaxis, along with rabies vaccine, for all persons suspected of exposure to rabies.

Limitations of Use

Persons previously immunized with rabies vaccine that have a confirmed adequate rabies antibody titer should receive only vaccine.

For unvaccinated persons, the combination of HYPERRAB and vaccine is recommended for both bite and nonbite exposures regardless of the time interval between exposure and initiation of postexposure prophylaxis.

Beyond 7 days (after the first vaccine dose), HYPERRAB is not indicated since an antibody response to vaccine is presumed to have occurred.

Source: the FDA label for HyperRAB (GRIFOLS USA, LLC), September 20, 2024. Full label on DailyMed 

Good to know

Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/hyperrab/